文献速递乳腺技术与安全乳腺X线

医疗保险优势计划中乳腺X线筛查率的差异

Variation in Screening Mammography Rates Among Medicare Advantage Plans.
PubMed 文献 · J Am Coll Radiol · 2017-05-27

该研究利用2016年医疗保险优势计划(MA)医疗保健效果数据与信息集公共使用文件,分析了全部385个上报MA计划的乳腺X线筛查率及其与计划特征的关系。结果显示MA计划总体筛查率较高(均值72.6±9.4%),但计划间差异很大(范围14.3%-91.8%),非营利计划高于营利计划(77.3%对71.8%,P<.001),健康维护组织或地方优选提供者组织计划高于私人按服务付费或区域优选提供者组织计划(71.9%-73.2%对65.5%-66.8%,P=.001)。作者结论认为MA计划间筛查率差异显著,随着联邦对MA项目关注增加,需增强透明度以保障受益人参与决策。

要点

  • MA计划乳腺X线筛查率均值72.6±9.4%,但计划间范围14.3%-91.8%,差异显著。
  • 非营利计划筛查率77.3%高于营利计划71.8%(P<.001)。
  • 健康维护组织或地方优选提供者组织计划筛查率71.9%-73.2%,高于私人按服务付费或区域优选提供者组织计划65.5%-66.8%(P=.001)。

核心结论

  • MA计划间乳腺X线筛查率差异很大,非营利计划、健康维护组织或地方优选提供者组织计划筛查率更高;随着联邦对MA项目关注增加,需增强透明度以保障受益人参与决策。

研究设计与样本

  • 基于2016年MA医疗保健效果数据与信息集公共使用文件的计划层面分析,纳入全部385个上报MA计划,结合CMS Part C和Part D Medicare星级评定数据文件、MA计划目录及按月参保文件中的计划特征进行关联探索。

诊断标准与关键数值

  • 总体MA计划乳腺X线筛查率均值72.6±9.4%,范围14.3%-91.8%。
  • 非营利计划筛查率77.3%对营利计划71.8%,P<.001。
  • 健康维护组织或地方优选提供者组织计划筛查率71.9%-73.2%对私人按服务付费或区域优选提供者组织计划65.5%-66.8%,P=.001。
  • 拥有五个及以上计划的母组织中,Kaiser Foundation筛查率中位数最高(88.4%),Molina Healthcare最低(中位数65.3%)。
  • 筛查率与结直肠癌筛查及年度流感疫苗接种率呈强关联(r=0.796-0.798),与门诊及预防保健就诊、骨质疏松筛查、体重指数评估及70岁后不推荐的前列腺特异性抗原筛查呈中等关联(r=0.283-0.365)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Prior studies have shown higher screening mammography rates for beneficiaries in capitated managed care Medicare Advantage (MA) plans compared with traditional fee-for-service Medicare. The aim of this study was to explore variation in screening mammography rates at the level of MA managed care plans.

METHODS: Using the 2016 MA Healthcare Effectiveness Data and Information Set Public Use File, screening mammography rates were identified for all 385 reporting MA plans. Associations were explored with a range of plan characteristics from this file, as well as from the CMS Part C and Part D Medicare Star Ratings Data File, Medicare Advantage Plan Directory, and Medicare Monthly Enrollment by Plan File.

RESULTS: Overall MA plan screening rates were high (mean, 72.6 ± 9.4%) but varied substantially among plans (range, 14.3%-91.8%). Screening rates were higher in nonprofit versus for-profit plans (77.3% versus 71.8%, P < .001), as well as in health maintenance organization or local preferred provider organization plans versus private fee-for-service or regional preferred provider organization plans (71.9%-73.2% versus 65.5%-66.8%, P = .001). Among parent organizations with five or more plans, screening rates were highest for Kaiser Foundation (median, 88.4%) and lowest for Molina Healthcare (median, 65.3%). Screening rates showed small but significant associations with plans' contract lengths, enrolled populations, and counties served. Screening rates showed strong associations (r = 0.796-0.798) with colorectal cancer screening and annual flu vaccine rates and showed moderate associations (r = 0.283-0.365) with ambulatory and preventive care visits, osteoporosis screenings, body mass index assessments, and nonrecommended prostate-specific antigen screenings after age 70.

CONCLUSIONS: Screening mammography rates vary considerably among MA plans. With increased federal interest in promoting the MA program, enhanced transparency will be necessary to ensure appropriate Medicare beneficiary participation decision making.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Rosenkrantz AB, Fleming M, Duszak R, et al. Variation in Screening Mammography Rates Among Medicare Advantage Plans. J Am Coll Radiol. 2017. PMID: 28566133. doi:10.1016/j.jacr.2017.01.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。